Skip to content

Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease.

Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease: A Multicenter Prospective Cohort Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04539665
Enrollment
30
Registered
2020-09-07
Start date
2019-09-27
Completion date
2024-06-30
Last updated
2022-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn Disease, Crohn's Ileocolitis, Recurrence

Brief summary

The study is looking at the role of the mesentery in disease recurrence for ileocolic Crohn's disease. It is a prospective study that has been designed to perform extended mesenteric excision on patients undergoing their first ileocolic resection for Crohn's disease. Endoscopic recurrence will be monitored with the hypothesis that patients receiving extended mesenteric ileocolic resection will have reduced endoscopic recurrence at 6 months after resection.

Detailed description

The current standard of care for ileocolic Crohn's disease (CD) is a limited mesenteric resection. There is growing, but still limited, evidence that extended mesenteric excision during ileocolic resection is beneficial in decreasing disease recurrence. We propose a prospective multicenter cohort study to better understand the role of extended mesenteric excision in ileocolic CD and how it affects disease recurrence. The primary outcome of this study will be the rate of endoscopic recurrence at 6 months in patients undergoing first-time resection for ileocolic CD. Secondary outcomes will include endoscopic recurrence at 18 months and rates of recurrence requiring surgery by 2 years. These outcomes will be compared to historical controls (limited mesenteric resection). Our hypothesis is that patients receiving extended mesenteric ileocolic resection will have reduced endoscopic recurrence at 6 months after resection. As seen in previous studies, advanced mesenteric and mucosal disease predicts increased surgical recurrence.

Interventions

PROCEDUREExtended mesenteric resection.

Patients will undergo an ileocolic resection involving high ligation of the ileocolic pedicle, complete mobilization of the mesentery off of the retroperitoneum, and resection of the entire mesentery related to the specimen.

Sponsors

Jewish General Hospital
CollaboratorOTHER
Montreal General Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* adults \>18 years old * diagnosis of CD limited to the distal ileum/ileocolic region * no previous ileocolic resection * all forms of CD presentation will be included - stricturing, fistulizing, perforating etc.

Exclusion criteria

* previous ileocolic resection * other sites of CD * intraabdominal sepsis

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with endoscopic recurrence at 6 months6 monthsEndoscopic recurrence after extended mesenteric ileocolic resection

Secondary

MeasureTime frameDescription
Number of participants with endoscopic recurrence at 18 months18 monthsEndoscopic recurrence after extended mesenteric ileocolic resection.
Rates of recurrence requiring surgery by 2 years24 monthsSurgical recurrence after extended mesenteric ileocolic resection.
Rates of post-operative complications compared between study groups30 daysPost-operative complications including: wound infections, anastomotic leak, intra-abdominal abscess, venous-thromboembolic complications, and primary ileus within 30 days of the first resection.

Countries

Canada

Contacts

Primary ContactSender Liberman, MD
sender.liberman@mcgill.ca(514) 934-8486
Backup ContactMarylise Boutros, MD
maryliseboutros@gmail.com(514) 340-8222

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026